Sunitinib-induced hand-foot syndrome in a Kashmiri male
Keywords:
Sunitinib, tyrosine kinase inhibitor, renal cell carcinoma, hand-foot syndromeAbstract
Sunitinib belongs to multiple tyrosine kinase inhibitor class of novel targeted therapies used for metastatic solid tumours including renal cell carcinoma. A variety of systemic, as well as, cutaneous side effects due to sunitinib have been described including the hand foot syndrome. We report sunitinib-induced hand foot syndrome in a 65-year-old Kashmiri male and review the literature.References
Degen A, Alter M, Schenck F et al. The hand-foot-syndrome associated with medical tumor therapy - classification and management. J Dtsch Dermatol Ges. 2010;8:652-61.
Lipworth AD, Robert C, Zhu AX. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology. 2009;77:257-71.
Jeong JS, Yun JH, Yoon SJ et al. Two cases of hand-foot syndrome induced by sunitinib. Korean J Dermatol. 2008;46:1236-39.
Zuehlke RL. Erythematous eruption of the palms and soles associated with mitotane therapy. Dermatologica. 1974;148:90-2.
Hueso L, Sanmartin O, Nagore E et al. Chemotherapy induced acral erythema: A clinical and histopathological study of 44 cases. Actas Dermosifiliogr. 2008;99:281-90.
Demircay Z, Gurbuz O, Alpdogan T et al. Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases. Int J Dermatol. 1997;36:593-8.
Apisarnthanarax N, Duvic MM. Dermatologic complications of cancer chemotherapy. In: Kufe DW, Pollock RE, Weichselbaum RR et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003.
Webster-Gandy JD, How C, Harrold K. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs. 2007;11:238-46.
Lacouture ME, Reilly LM, Gerami P, Guitart J. Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Ann Oncol. 2008;19:1955-61.
Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol. 1991;24:457-61.
